These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15567318)

  • 21. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
    Lohrmann M; Kappl M; Butt HJ; Urbanetz NA; Lippold BC
    Eur J Pharm Biopharm; 2007 Sep; 67(2):579-86. PubMed ID: 17418548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):72-80. PubMed ID: 16442248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dry powder aerosol delivery of large hollow nanoparticulate aggregates as prospective carriers of nanoparticulate drugs: effects of phospholipids.
    Hadinoto K; Phanapavudhikul P; Kewu Z; Tan RB
    Int J Pharm; 2007 Mar; 333(1-2):187-98. PubMed ID: 17084567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effervescent dry powder for respiratory drug delivery.
    Ely L; Roa W; Finlay WH; Löbenberg R
    Eur J Pharm Biopharm; 2007 Mar; 65(3):346-53. PubMed ID: 17156987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adhesion and redistribution of salmeterol xinafoate particles in sugar-based mixtures for inhalation.
    Adi H; Larson I; Stewart PJ
    Int J Pharm; 2007 Jun; 337(1-2):229-38. PubMed ID: 17303354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel sustained release microspheres for pulmonary drug delivery.
    Cook RO; Pannu RK; Kellaway IW
    J Control Release; 2005 May; 104(1):79-90. PubMed ID: 15866336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polydisperse powder mixtures: effect of particle size and shape on mixture stability.
    Swaminathan V; Kildsig DO
    Drug Dev Ind Pharm; 2002 Jan; 28(1):41-8. PubMed ID: 11858523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Micro-particle corrugation, adhesion and inhalation aerosol efficiency.
    Adi S; Adi H; Tang P; Traini D; Chan HK; Young PM
    Eur J Pharm Sci; 2008 Sep; 35(1-2):12-8. PubMed ID: 18586091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Particle size of fillers affects permeability of polymethylmethacrylate.
    McLaren AC; McLaren SG; McLemore R; Vernon BL
    Clin Orthop Relat Res; 2007 Aug; 461():64-7. PubMed ID: 17762329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
    Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of dose on the performance of dry powder inhalation systems.
    Young PM; Edge S; Traini D; Jones MD; Price R; El-Sabawi D; Urry C; Smith C
    Int J Pharm; 2005 May; 296(1-2):26-33. PubMed ID: 15885452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agglomeration rate and action forces between atomized particles of agglomerator and inhaled-particles from coal combustion.
    Wei F; Zhang JY; Zheng CG
    J Environ Sci (China); 2005; 17(2):335-9. PubMed ID: 16295917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of erythritol and lactose monohydrate as carriers for inhalation: atomic force microscopy and in vitro correlation.
    Traini D; Young PM; Jones M; Edge S; Price R
    Eur J Pharm Sci; 2006 Feb; 27(2-3):243-51. PubMed ID: 16330191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of drug load on the aerosolisation propensity of binary adhesive mixtures for inhalation.
    Simonsson A; Bramer T; Wimbush A; Alderborn G
    Int J Pharm; 2024 May; 657():124122. PubMed ID: 38621619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
    Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
    J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery.
    Dhumal RS; Biradar SV; Paradkar AR; York P
    Int J Pharm; 2009 Feb; 368(1-2):129-37. PubMed ID: 18996462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the effect of latex particle size and distribution on the rheological and adhesive properties of model waterborne acrylic pressure-sensitive adhesives films.
    do Amaral M; Roos A; Asua JM; Creton C
    J Colloid Interface Sci; 2005 Jan; 281(2):325-38. PubMed ID: 15571688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles.
    Azarmi S; Tao X; Chen H; Wang Z; Finlay WH; Löbenberg R; Roa WH
    Int J Pharm; 2006 Aug; 319(1-2):155-61. PubMed ID: 16713150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.